Immune Markers and Inflammatory Cytokines in Granulomatous Lobular Mastitis: A Case-Control Study
Jifeng Li,Yifei Zeng,Mengjie Wang,Yongxin Liu,Yubo Guo,Wenjie Zhao,Qiao Huang,Dongxiao Zhang
DOI: https://doi.org/10.2147/jir.s492464
IF: 4.5
2024-11-13
Journal of Inflammation Research
Abstract:Jifeng Li, Yifei Zeng, Mengjie Wang, Yongxin Liu, Yubo Guo, Wenjie Zhao, Qiao Huang, Dongxiao Zhang Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, People's Republic of China Correspondence: Dongxiao Zhang, Department of Galactophore Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, No. 23, Art Museum Back Street, Dongcheng District, Beijing, 100010, People's Republic of China, Tel +8617864190977, Email Purpose: Granulomatous lobular mastitis (GLM) has seen a rising incidence, though its pathogenesis remains unclear, posing challenges for treatment and contributing to high recurrence rates with conventional therapies. While the role of inflammatory and immune factors in GLM has been recognized, a comprehensive clinical evaluation of these markers is still lacking. This study aims to identify potential diagnostic markers and therapeutic targets by comparing immune markers and cytokine levels in GLM patients and healthy controls. Methods: Conducted at Beijing Hospital of Traditional Chinese Medicine, Capital Medical University from July 2023 to May 2024, this study enrolled 30 GLM patients and 15 healthy female controls in a 2:1 ratio. Serum levels of immune markers and cytokines were analyzed to explore their potential association with GLM. Results: The study population comprised 30 GLM patients with a mean age of 33.40 ± 4.12 years and 15 healthy female controls with a mean age of 32.13 ± 6.19 years. Significantly elevated levels of C-reactive protein (CRP), Immunoglobulin A (IgA), Complement Component 3 (C3), Complement Component 4 (C4), Compliment Component 1q (C1q), Alpha1-antit-rypsin (AAT), α 1-acidglycoprotein (AGP), Anti-histone antibodies (Anti-HIS), Anti-Ro52 antibodies (Anti-Ro52), Anti-double stranded DNA antibodies (Anti-dsDNA), Interleukin-6 (IL-6), Interleukin-10 (IL-10), and Tumor Necrosis Factor-α (TNF-α) were observed in GLM patients compared to controls (all P < 0.05). Subgroup analysis revealed higher levels of CRP, C3, C1q, AAT, and AGP in patients with larger mass areas and those with erythema nodosum (all P 0.05). Conclusion: Serum levels of CRP, IgA, AAT, AGP, Anti-HIS, Anti-Ro52, Anti-dsDNA, C3, C4, C1q, IL-6, IL-10, and TNF-α may serve as diagnostic and prognostic indicators for GLM, with CRP, AAT, AGP, and C1q being particularly indicative of disease severity. These markers offer potential therapeutic targets for GLM. Keywords: granulomatous lobular mastitis, peripheral serology, immune markers, cytokine Granulomatous mastitis is a chronic inflammatory disease centered on breast lobules with non-caseating necrotizing granulomas as the main pathological feature. 1,2 Despite extensive investigation, the precise etiology of GLM remains elusive, and its pathogenesis is not yet fully understood. Recent research has suggested various potential risk factors, including autoimmune dysregulation, nipple inversion, hormonal imbalances, and localized breast trauma. 3–5 These factors are hypothesized to trigger a type IV hypersensitivity reaction, leading to an imbalance in immune markers and inflammatory mediators. Consequently, treatment approaches include the use of immunosuppressive agents, 6 corticosteroid therapy, 7 and medications that target specific inflammatory pathways. 8–10 However, the key immune markers and cytokines involved in GLM have yet to be clearly identified. The majority of existing literature is based on animal models or limited by retrospective clinical studies, often lacking healthy control groups. To address these limitations, the current study enrolled 30 female GLM patients and 15 healthy female controls in a 2:1 ratio. Both groups underwent assessment of immune markers (IM) and inflammatory cytokines (CK). The IM included complement levels, antinuclear antibodies, immunoglobulins, acute-phase proteins, and rheumatoid factors, while cytokines assessed included interleukins, interferons (INF), and tumor necrosis factors (TNF). This systematic evaluation aimed to identify differences in immunoserology and cytokines between GLM patients and healthy individuals, thereby providing potential diagnostic markers and therapeutic targets for GLM. Futhermore, subgroup analyses of GLM patients with clinical symptoms were conducted to explore the correlation between serum immune markers, cytokines, and disease severity. The study group consisted of 30 patients with a confirmed diagnosis of granulomatous lobular mastitis (GLM) who visited the Galactophore Department in Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, between July 202 -Abstract Truncated-
immunology